UniSuper Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

UniSuper Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,256	Closed	-$1.16M	–	753
2024 Q2	$1.16M	Buy	4,256 +1,391	+49%	+$405K	0.01%	553
2024 Q1	$991K	Buy	2,865 +2,447	+585%	+$805K	0.01%	542
2023 Q4	$135K	Buy	418 +45	+12%	+$14.1K	﹤0.01%	609
2023 Q3	$134K	Sell	373 -33	-8%	-$12.7K	﹤0.01%	529
2023 Q2	$154K	Buy	+406	New	+$165K	﹤0.01%	511

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UniSuper Management's BIO Position: Q3 2024 in Review

UniSuper Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 4,256 shares — an estimated $1.16M sold.

UniSuper Management first reported a position in BIO in Q2 2023 and held it in 5 quarters. The position peaked at $1.16M in Q2 2024. 437 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

UniSuper Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
UniSuper Management sold 4,256 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $1.16M.
UniSuper Management first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and held it in 5 quarters.
UniSuper Management's Bio-Rad Laboratories Class A position peaked at $1.16M in Q2 2024.
437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on UniSuper Management's 13F filing for Q3 2024, filed 14 Nov 2024.